APA (7th ed.) Citation

Iannantuono, G., Filetti, M., Giudice, E., Sganga, S., Chandran, E., Xue, E., . . . Daniele, G. (2024). 1585P Performance status restrictions in clinical trials leading to US food and drug administration (FDA) drug approval: A cross-sectional study of a decade (2014-2023). Annals of Oncology, 35, S956. https://doi.org/10.1016/j.annonc.2024.08.1647

Chicago Style (17th ed.) Citation

Iannantuono, G.M, et al. "1585P Performance Status Restrictions in Clinical Trials Leading to US Food and Drug Administration (FDA) Drug Approval: A Cross-sectional Study of a Decade (2014-2023)." Annals of Oncology 35 (2024): S956. https://doi.org/10.1016/j.annonc.2024.08.1647.

MLA (9th ed.) Citation

Iannantuono, G.M, et al. "1585P Performance Status Restrictions in Clinical Trials Leading to US Food and Drug Administration (FDA) Drug Approval: A Cross-sectional Study of a Decade (2014-2023)." Annals of Oncology, vol. 35, 2024, p. S956, https://doi.org/10.1016/j.annonc.2024.08.1647.